Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
March 10, 2023 11:10 AM 2 min read

What These 4 DocuSign Analysts Have To Say About Q4 Print

by Priya Nigam Benzinga Staff Writer
Follow

Shares of DocuSign Inc (NASDAQ:DOCU) fell in the premarket on Friday, even after the company reported better-than-expected fourth-quarter earnings.

  • Morgan Stanley analyst Josh Baer maintained an Underweight rating and price target of $48.
  • JMP Securities analyst Patrick Walravens reaffirmed a Market Outperform rating and price target of $84.
  • RBC Capital Markets analyst Rishi Jaluria maintained a Sector Perform rating, while raising the price target from $53 to $59.
  • Needham analyst Scott Berg maintained a Hold rating on the stock.

Check out other analyst stock ratings.

Morgan Stanley

  • Although DocuSign reported strong fourth-quarter results that beat the consensus estimates, investors had expected the second RIF restructuring to flow to fiscal 2024 margins, Baer said.
  • “Instead, FY24 margin outlook improved by only ~1% while rest of savings reinvested in R&D,” he added.

JMP Securities

  • The company reported better than expected results and “generally in line to good” guidance, Walravens said in a note.
  • “While DocuSign is in transition and facing a difficult macroeconomic environment, we continue to like this story for a number of reasons,” the analyst wrote. There is a “shift of investment from the sales organization to product development with a focus on using AI to help create smarter agreements and save customers time.”

RBC Capital Markets

  • “DocuSign delivered in-line results with disappointing FY24 guidance,” Jaluria said.
  • “FY24 billings guidance of 2% growth was in-line to slightly below expectations, but the bigger surprise was guidance implying muted margin expansion, as investors expected the cumulative ~20% reduction in the workforce since September to lead to a better margin outlook,” the analyst wrote. “Instead, management plans to reinvest in self-service / PLG and R&D in order to help turnaround the business / growth profile."

Needham

DOCU Price Action: Shares of DocuSign had declined by 12.76% to $56.19 in the premarket session on Friday.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorEarningsNewsPrice TargetReiterationTop StoriesAnalyst RatingsMoversTrading IdeasExpert IdeasJMP SecuritiesMorgan StanleyNeedhamPatrick WalravensRBC Capital MarketsRishi JaluriaScott Berg
DOCU Logo
DOCUDocusign Inc
$44.63-0.43%
Overview
  • “Expectations of macro pressures on both net new and expansion sales are pressuring initial FY24 billings guidance of 2% which we believe was disappointing versus prior commentary on a mid-single digit growth expectation,” Berg said.
  • “On the positive side, relatively new CEO Allan Thygesen stressed a greater emphasis on product innovation which we believe will be a welcome development for DOCU shareholders seeking clarity on where the company's next growth leg comes from,” he added.
DOCU Logo
DOCUDocusign Inc
$44.63-0.43%
Overview
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter
Comments
Loading...